Epiminder

Epiminder company information, Employees & Contact Information

Explore related pages

Related company profiles:

Epilepsy is a complex neurological condition affecting over 80 million people globally, with a significant part of the patient population not responding to traditional medication. Epilepsy not only imposes chronic, debilitating effects but also subjects patients to the unpredictable nature of when and how seizures might occur. Epiminder is revolutionizing epilepsy care with its implantable continuous EEG monitoring (iCEM) system, the Minder® system. Currently Minder® is undergoing clinical trials and is for investigational use only. Seizure diaries are often unreliable, the true picture of a patient's condition may be different from what it initially appears. This creates gaps in understanding of what treatments should be deployed to address the patient’s underlying condition. The Minder® system will address this gap by unveiling continuous and objective EEG data that would not otherwise be seen. Like other diagnostic devices used in conditions requiring continuous monitoring of physiological signals (e.g. implantable cardiac monitors and continuous glucose monitors), the Minder® system represents a significant leap forward in epilepsy care, providing objective insights that enable informed clinical actions. Headquartered in Melbourne, Australia, with an office in Dallas, TX, USA, Epiminder is a privately held company dedicated to advancing neurological health.

Company Details

Employees
27
Founded
-
Address
Melbourne, Au
Email
cl****@****der.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Melbourne
Looking for a particular Epiminder employee's phone or email?

Epiminder Questions

News

Epiminder Announces Appointment of Mark McLellan as Chief Financial Officer - Business Wire

Epiminder Announces Appointment of Mark McLellan as Chief Financial Officer Business Wire

FDA Grants Authorization to Epiminder’s Implantable Continuous EEG Monitor for Epilepsy Treatment - NeurologyLive

FDA Grants Authorization to Epiminder’s Implantable Continuous EEG Monitor for Epilepsy Treatment NeurologyLive

Brokers throw open $125m Epiminder IPO book; Cochlear in for $10m - AFR

Brokers throw open $125m Epiminder IPO book; Cochlear in for $10m AFR

Subscalp EEG system feasible for long-term seizure monitoring in epilepsy - Healio

Subscalp EEG system feasible for long-term seizure monitoring in epilepsy Healio

Epiminder Announces Publication of Landmark Clinical Trial Confirming Safety and Efficacy of the Minder® System - Business Wire

Epiminder Announces Publication of Landmark Clinical Trial Confirming Safety and Efficacy of the Minder® System Business Wire

FDA grants Breakthrough approval for Epiminder’s Implantable EEG System for epilepsy monitoring - Medical Economics

FDA grants Breakthrough approval for Epiminder’s Implantable EEG System for epilepsy monitoring Medical Economics

Epiminder study backs implantable EEG tech - MassDevice

Epiminder study backs implantable EEG tech MassDevice

Epiminder wins FDA de novo nod for implantable continuous EEG monitor - MassDevice

Epiminder wins FDA de novo nod for implantable continuous EEG monitor MassDevice

Cochlear-backed Epiminder hunts cornerstones for $100m-plus IPO - AFR

Cochlear-backed Epiminder hunts cornerstones for $100m-plus IPO AFR

Epiminder reports trial outcomes of implantable EEG monitoring device - Medical Device Network

Epiminder reports trial outcomes of implantable EEG monitoring device Medical Device Network

With U.S. HQ in Dallas, Epiminder Gets FDA Authorization for Implantable Monitor for Epilepsy Patients - Dallas Innovates

With U.S. HQ in Dallas, Epiminder Gets FDA Authorization for Implantable Monitor for Epilepsy Patients Dallas Innovates

Epiminder wins de novo clearance for epilepsy EEG monitor - BioWorld MedTech

Epiminder wins de novo clearance for epilepsy EEG monitor BioWorld MedTech

Epiminder is pioneering an implant to help those with epilepsy - InnovationAus.com

Epiminder is pioneering an implant to help those with epilepsy InnovationAus.com

Cochlear-backed Epiminder targets 2025 IPO as FDA authorisation lands - AFR

Cochlear-backed Epiminder targets 2025 IPO as FDA authorisation lands AFR

Epiminder’s implantable EEG system for epilepsy receives FDA authorisation - Medical Device Network

Epiminder’s implantable EEG system for epilepsy receives FDA authorisation Medical Device Network

Cochlear backs medtech startup EpiMinder in $16 million bridge funding round - Startup Daily

Cochlear backs medtech startup EpiMinder in $16 million bridge funding round Startup Daily

FDA Action Update, April 2025: Approvals, Expansion, and Authorization - NeurologyLive

FDA Action Update, April 2025: Approvals, Expansion, and Authorization NeurologyLive

Cochlear-backed Epiminder raises $16m to expand epilepsy monitoring device trials - Business News Australia

Cochlear-backed Epiminder raises $16m to expand epilepsy monitoring device trials Business News Australia

Australia’s Epi-Minder raises AU$18M series A to test seizure monitoring device - BioWorld MedTech

Australia’s Epi-Minder raises AU$18M series A to test seizure monitoring device BioWorld MedTech

Cochlear-backed medtech Epiminder seeks $200m val in pre-IPO raise - AFR

Cochlear-backed medtech Epiminder seeks $200m val in pre-IPO raise AFR

Cochlear-backed Aussie innovator raises $16m to test seizure epilepsy monitoring device - Australian Manufacturing

Cochlear-backed Aussie innovator raises $16m to test seizure epilepsy monitoring device Australian Manufacturing

New collaboration for Epiminder and Seer Medical - BiotechDispatch

New collaboration for Epiminder and Seer Medical BiotechDispatch

Top Epiminder Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant